Item 7.01 Regulation FD Disclosure.
On September 16, 2020, Heron Therapeutics, Inc. issued a press release
announcing that the results from EPOCH 2 follow-on study (NCT03695367) of the
investigational agent HTX-011 in open inguinal hernia repair surgery with mesh,
have been published online by the journal, Surgery in an article entitled
"Opioid-free recovery following herniorrhaphy with HTX-011 as the foundation of
a multimodal analgesic regimen," as described in the press release furnished
herewith as Exhibit 99.1.
Item 9.01 Financial Statements and Exhibits.
(d) Exhibits.
Exhibit No. Description
99.1 Press Release, dated September 16, 2020
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
--------------------------------------------------------------------------------
© Edgar Online, source Glimpses